Nitric Oxide-Releasing Chitosan for the Treatment of Multi-Drug Resistant Superbugs

BACKGROUND: Multi-drug resistant superbugs are a serious health threat due to limited treatment options and high mortality rates. Certain superbug strains are now resistant to as many as 36 representative FDA-approved antibiotics, including Colistin and Carbapenem antibiotics, widely considered as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kougoulos, Terry, Schoenfisch, Mark, Cruz, Pedro De Jesus, Ahonen, Mona, Fisher, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631293/
http://dx.doi.org/10.1093/ofid/ofx163.1231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631293/
http://dx.doi.org/10.1093/ofid/ofx163.1231

Ejemplares similares